EPS Bio Technology Corp. (TPEX:4183)

EPS Bio Technology Revenue

EPS Bio Technology had revenue of 130.57M TWD in the quarter ending September 30, 2025, with 26.96% growth. This brings the company's revenue in the last twelve months to 497.19M, up 2.51% year-over-year. In the year 2024, EPS Bio Technology had annual revenue of 451.08M, down -4.06%.

• Revenue (ttm): 497.19M
• Revenue Growth: +2.51%
• P/S Ratio: 0.77
• Revenue / Employee: 4.56M
• Employees: 109
• Market Cap: 384.37M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	451.08M	-19.08M	-4.06%
Dec 31, 2023	470.17M	6.72M	1.45%
Dec 31, 2022	463.45M	-16.83M	-3.50%
Dec 31, 2021	480.28M	2.68M	0.56%
Dec 31, 2020	477.60M	18.25M	3.97%